- (-)-ALPHA-BISABOLOL
-
- $30.00 / 1kg
-
2024-04-12
- CAS:23089-26-1
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 2000kg
- (-)-ALPHA-BISABOLOL
-
- $0.00 / 25KG
-
2023-11-22
- CAS:23089-26-1
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- (-)-α-Bisabolol
-
- $0.00 / 1kg
-
2023-11-01
- CAS:23089-26-1
- Min. Order: 1kg
- Purity: 99.0%
- Supply Ability: 20 tons
|
| | (-)-ALPHA-BISABOLOL Basic information |
| | (-)-ALPHA-BISABOLOL Chemical Properties |
| alpha | D -55.7°; D20 -51.02° (Günther) | | Boiling point | bp12 153° | | density | d20 0.9211 | | vapor pressure | 0.015Pa at 20℃ | | FEMA | 4666 | ALPHA-BISABOLOL | | refractive index | n20/D 1.496 | | Fp | 135 °C | | storage temp. | -20°C | | solubility | DMSO:100.0(Max Conc. mg/mL);449.7(Max Conc. mM) | | pka | 15.04±0.29(Predicted) | | Odor | at 100.00 %. fruity nutty coconut | | Odor Type | floral | | optical activity | [α]/D -60±2°, neat | | Water Solubility | 22mg/L at 20℃ | | JECFA Number | 2031 | | LogP | 5.5 at 25℃ | | CAS DataBase Reference | 23089-26-1(CAS DataBase Reference) | | EPA Substance Registry System | Levomenol (23089-26-1) |
| RIDADR | UN 3082 9 / PGIII | | WGK Germany | 3 | | RTECS | MJ9685000 | | HS Code | 2906195000 | | Toxicity | LD50 in male, female mice, rats (ml/kg): 15.2, 15.0, 14.9, 15.6 orally (Habersang) |
| | (-)-ALPHA-BISABOLOL Usage And Synthesis |
| Uses | Reference Standard in the analysis of herbal medicinal products | | Uses | (-)-α-Bisabolol was used to investigate the leishmanicidal and cytotoxic activity of essential oil of Vanillosmopsis arborea. | | Definition | ChEBI: (-)-alpha-Bisabolol is a sesquiterpenoid. | | General Description | (-)-α-Bisabolol is the major constituent of essential oil from leaves of Hymenocrater yazdianus. | | Flammability and Explosibility | Not classified | | Biochem/physiol Actions | α-Bisabolol is active against primary acute leukemia cells, including BCR-ABL(+) acute lymphoblastic leukemias. It is the inhibitor of voltage-dependent Ca(2+) channels in tracheal smooth muscle preparations of rat. It also inhibits human and rat glioma cell growth and survival. It is a potential new therapeutic agent against leishmaniasis. |
| | (-)-ALPHA-BISABOLOL Preparation Products And Raw materials |
|